Stroke/Vascular Neurology News

The FDA has removed the clinical hold on the investigational new drug application for the phase 2/3 ReMEDy2 trial of DM199 for acute ischemic stroke, DiaMedica Therapeutics announced in a press release.

In patients with minor nondisabling acute ischemic stroke, treatment with dual antiplatelet therapy was noninferior to treatment with IV alteplase, according to the results of the ARAMIS trial.

Interatrial block was associated with elevated risk for stroke and other poor outcomes in patients with no history of atrial fibrillation, according to a retrospective study.

PHILADELPHIA — Direct oral anticoagulants for stroke prevention in patients with atrial fibrillation are safe in most high-risk populations, a speaker said during the Heart in Diabetes CME Conference.

AstraZeneca announced the ANNEXA phase IV trial assessing the safety and efficacy of andexanet alfa stopped early after achieving prespecified criteria on hemostatic efficacy vs. usual care, according to a press release.

African American men and women remain at higher risk for stroke even as overall stroke rates are decreasing, Bruce Ovbiagele, MD, MSc, MAS, MBA, MLS, says in this Healio video.

Approximately one in four stroke survivors will experience a second stroke within 5 years, according to data from the American Stroke Association, yet research shows many patients still do not receive adequate follow-up and support.

BOSTON — The BrainPath device successfully surgically evacuated intracerebral hemorrhages in most patients enrolled in the ENRICH trial, Andrew Russman, DO, said in a Healio video during the American Academy of Neurology Annual Meeting.

In patients with acute stroke and atrial fibrillation, oral anticoagulation therapy may be administered within 48 hours after stroke when appropriate or indicated, researchers reported.

BOSTON — In honor of Stroke Awareness Month, two vascular neurologists from the University of Virginia spoke with Healio at the American Academy of Neurology annual meeting about the importance of recognizing risk factors in all patients.